3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Prostatic Neoplasms
3
Herpes Zoster
3
Breast Neoplasms
3
Uterine Cervical Neoplasms
2
Uterine Cervical Dysplasia
2
Papillomavirus Infections
2
Neoplasms
2
Melanoma
2
Lung Neoplasms
2
Influenza, Human
2
Glioblastoma
2
Whooping Cough
1
Waldenstrom Macroglobulinemia
1
Tetanus
1
Spondylitis, Ankylosing
1
Psoriasis
1
Pancreatic Neoplasms
1
Neuroectodermal Tumors, Primitive
1
Neoplasms, Glandular and Epithelial
1
Multiple Myeloma
1
Meningitis
1
Medulloblastoma
1
Hematologic Neoplasms
1
Glioma
1
Diphtheria
1
Diabetes Mellitus, Insulin-Dependent, 12
1
Crohn Disease
1
Colonic Neoplasms
1
Carcinoma, Non-Small-Cell Lung
1
Breast Neoplasms, Male
1
Interventions
Carboplatin
23
Cisplatin
19
pembrolizumab
14
Paclitaxel
13
Gemcitabine
12
Pemetrexed
11
130-nm albumin-bound paclitaxel
9
Everolimus
8
Cetuximab
8
Fluorouracil
7
Docetaxel
6
Axitinib
6
Albumin-Bound Paclitaxel
6
osimertinib
5
durvalumab
5
Sunitinib
5
Radiotherapy
5
Nivolumab
5
Erlotinib Hydrochloride
5
Cyclophosphamide
5
Sorafenib
4
Radiation
4
Irinotecan
4
Ipilimumab
4
vosaroxin
3
Radiotherapy, Intensity-Modulated
3
Octreotide
3
Bevacizumab
3
1-(1-(imidazo(1,2-a)pyridin-6-yl)ethyl)-6-(1-methyl-1H-pyrazol-4-yl)-1H-(1,2,3)triazolo(4,5-b)pyrazine
3
trifluridine tipiracil drug combination
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Carcinoma
×
Vaccines
×
Clear all
No trials found.